Pharmacokinetic interactions of the new antiepileptic drugs

被引：56

作者：

Rambeck, B ^{[1
]}

Specht, U ^{[1
]}

Wolf, P ^{[1
]}

机构：

[1] EPILEPSY CTR BETHEL, KLIN MARA 1, BIELEFELD, GERMANY

来源：

CLINICAL PHARMACOKINETICS | 1996年 / 31卷 / 04期

关键词：

D O I：

10.2165/00003088-199631040-00006

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Therapy with traditional antiepileptic drugs is associated with a wide range of pharmacokinetic drug-drug interactions. In particular, enzyme induction, enzyme inhibition and displacement from protein binding may result in important changes in serum concentrations of antiepileptics. Relevant interactions have also been described for some new antiepileptics. Felbamate increases serum concentrations of phenytoin, phenobarbital and valproic acid (sodium valproate). On the other hand, it reduces concentrations of carbamazepine and increases concentrations of its metabolite carbamazepine-10,11-epoxide. Concentrations of felbamate itself are reduced by phenytoin and carbamazepine. Concentrations of lamotrigine are considerably increased by valproic acid and decreased by phenytoin, carbamazepine and phenobarbital

引用

页码：309 / 324

页数：16

共 121 条

[31] LAMOTRIGINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN EPILEPSY [J].